Marcus A. Ray

FDA investigator · also recorded as Sets Marcus A. Ray

Appears on 14 documents from 2017 to 2025, most often at sites in China. Most often cites general requirements (21 CFR 211.160).

14
Documents on file
5.8
Observations per 483
2017
First seen
2025
Most recent

What they cite most

From 81 observations

Activity by year

2017: 3, 2018: 4, 2019: 3, 2020: 1, 2022: 1, 2024: 1, 2025: 1

Where

China 4 · Virginia 3 · Maryland 2 · India 1 · Italy 1 · Pennsylvania 1

Is Marcus A. Ray coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

14 documents, newest first
FirmOpen
483 Shouguang Fukang Pharmaceut ical CoFeb 21, 2025 · Shouguang City, China
483 Form 483 · FEI 3017734754Apr 16, 2024 · ALCALA DE HENARES, Spain
483 Zhejiang Tianyu Pharmaceutical Co. LtdMar 4, 2022 · Taizhou City, China
483 Shandong Anshun Pharmaceutical Co., Ltd.Nov 20, 2020 · Dezhou City, China
483 Yichang Humanwell Oral Solid Dosage PlantJun 28, 2019 · Yichang, China
483 ICROM SRLMar 22, 2019 · Concorezzo, Italy
483 RECIPHARM PHARMASERVICES PRIVATE LIMITEDFeb 1, 2019 · Bengaluru, India

About this profile

What does Marcus A. Ray inspect?

Marcus A. Ray appears on 14 documents on file covering 14 sites, most often in China.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.192 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Marcus A. Ray is dated Feb 21, 2025.

FDA Investigator Marcus A. Ray: 483s & Inspections · FDA Intel